IT
Invea Therapeutics, Inc
SEC filingBiotechnology · Guilford, CT
Amount raised$120Ksold at filing
Total offering$120K
Investors in the raise1count reported to the SEC
FiledDec 10, 2025first sale Oct 31, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Demetrios J. KydonieusDirector
Aman KantExecutive Officer
Salvatore J. AlesciExecutive Officer
Michael J. AielloExecutive Officer
Jonathan J. ZalevskyDirector
"Shunichiro ""Steve""" J. OkadaExecutive Officer
Stephen J. DobersteinDirector
Kerrie J. BradyDirector
Krishnan NandabalanExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.